TLR4 and early-onset autosomal dominant Alzheimer disease: Remarkably, when administered to mice with an Alzheimer’s disease model, Pls were found to significantly reduce TLR4 endocytosis, providing further evidence for the anti-inflammatory effects of 1-O-alkyl-glycerols through an additional molecular mechanism.